Case ReportIdiopathic Cholestasis as a Paraneoplastic Phenomenon in Hodgkin's Lymphoma
References (44)
- et al.
Jaundice in Hodgkin's disease
Amer J Med
(1961) Prolonged severe obstructive jaundice in Hodgkin's disease
Gastroenterology
(1963)- et al.
Investigation of a patient with Hodgkin's disease and cholestasis
Gastroenterology
(1979) - et al.
Resolution of paraneoplastic bile duct paucity following successful treatment of Hodgkin's disease
Hepatology
(1997) - et al.
Drug-induced cholestasis
Clin Liver Dis
(2003) The syndrome of disappearing bile ducts
Lancet
(1987)- et al.
Challenging paradigms in lymphoma treatment
Ann Oncol
(2004) Problems in Hodgkin's disease management
Blood
(1999)- et al.
Bile duct disorders
Clin Liver Dis
(2003) - et al.
Differential diagnosis of jaundice in lymphoma patients
Seminars in Liver Disease
(1987)
Hepatic involvement in Hodgkin's disease
Cancer
(1989)
Hepatic manifestations of systemic disease and other disorders of the liver
Pathogenesis of jaundice in Hodgkin's disease
Arch Intern Med
(1962)
Diagnosis of malignant lymphoma at laparotomy disclosing intrahepatic cholestasis
Acta Chir Scand
(1972)
Cholestasis associated with extrabiliary Hodgkin's disease
Gastroenterology
(1974)
Liver disease as presenting manifestation of Hodgkin's disease
Quart J Med
(1979)
Intrahepatic cholestasis due to Hodgkin's disease: an elusive diagnosis
J Clin Gastroenterol
(1986)
Extrahepatic Hodgkin's disease and cholestasis
Am J Gastroenterol
(1994)
Intrahepatic cholestasis and biliary cirrhosis associated with extrahepatic Hodgkin's disease
Neth J Med
(1994)
Extrahepatic Hodgkin's disease with intrahepatic cholestasis: report of 2 cases;
Oncology
(1999)
Hodgkin's disease presenting as cholestatic hepatitis with prominent ductal injury
Eur J Gastroenterol Hepatol
(2002)
Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma
Hepatology
(1993)
Cited by (25)
Successful Treatment of Paraneoplastic Cholestasis in Relapsed/Refractory Hodgkin Lymphoma With Bridging Therapy and Checkpoint Blockade
2020, Clinical Lymphoma, Myeloma and LeukemiaCitation Excerpt :VBDS is characterized by loss of bile ducts in more than 50% of the portal tracts in an adequate-sized biopsy.2 On the other hand, IC is characterized by canalicular stasis and a mixed inflammatory infiltrate without ductopenia.3,4 In the past, many authors have emphasized on distinguishing the 2 entities.3,5
Deeper Insights into Vanishing Bile Duct Syndrome in Lymphoma: A Perplexing Entity
2016, Clinical Lymphoma, Myeloma and LeukemiaPolymorphisms in ABCB11 and ATP8B1 Associated with Development of Severe Intrahepatic Cholestasis in Hodgkin's Lymphoma
2013, Journal of Clinical and Experimental HepatologyIcteric Variant of Stauffer Syndrome as a Paraneoplastic Manifestation of Type 1 Papillary Renal Cell Carcinoma
2023, ACG Case Reports JournalInflammation-induced cholestasis in cancer cachexia
2021, Journal of Cachexia, Sarcopenia and Muscle
Electronic forwarding or copying is a violation of US and International Copyright Laws.
Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by CIG Media Group, LP, ISSN #1557-9190, provided the appropriate fee is paid directly to Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923 USA 978-750-8400.
Copyright © 2006 Elsevier Inc. All rights reserved.